Visualizing vesicular dopamine dynamics in Parkinson's disease

It has been suggested that dopamine derived from exogenous levodopa may not follow vesicular dynamics in Parkinson's disease (PD). Using a novel PET method based on the sensitivity of [11C]‐dihydrotetrabenazine (DTBZ) binding to changes in vesicular dopamine levels, we show here that striatal [11C]‐DTBZ binding decreases after levodopa administration in advanced PD, likely reflecting an increase in vesicular dopamine levels. Endogenous dopamine and exogenously derived dopamine seem to follow the same vesicular dynamics. Synapse 63:713–716, 2009. © 2009 Wiley‐Liss, Inc.

[1]  K. Frey,et al.  Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain , 2008, NeuroImage.

[2]  Alan A. Wilson,et al.  Dopamine modulating drugs influence striatal (+)‐[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration , 2008, Synapse.

[3]  Anders Björklund,et al.  Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. , 2007, Brain : a journal of neurology.

[4]  Vesna Sossi,et al.  Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. , 2004, Brain : a journal of neurology.

[5]  D. Calne,et al.  Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. , 2004, Brain : a journal of neurology.

[6]  Mark Guttman,et al.  VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET , 2003, Synapse.

[7]  J. Labandeira-Garcia,et al.  Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum , 2001, Neuroscience.

[8]  M Schulzer,et al.  Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. , 2001, Annals of neurology.

[9]  Vesna Sossi,et al.  Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover , 2001 .

[10]  K. Frey,et al.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.

[11]  R. Wurtman,et al.  Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease , 1980, Nature.

[12]  Irwin J. Kopin,et al.  The Biochemical Basis of Neuropharmacology , 1971, The Yale Journal of Biology and Medicine.

[13]  R. Edwards,et al.  The role of vesicular transport proteins in synaptic transmission and neural degeneration. , 1997, Annual review of neuroscience.